Zoetis's latest marketcap:
As of 06/26/2025, Zoetis's market capitalization has reached $69.36 B. According to our data, Zoetis is the 303th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 69.36 B |
| Revenue (ttm) | 9.29 B |
| Net Income (ttm) | 2.52 B |
| Shares Out | 445.21 M |
| EPS (ttm) | 5.57 |
| Forward PE | 24.61 |
| Ex-Dividend Date | 07/18/2025 |
| Earnings Date | 08/05/2025 |
Zoetis's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | $69.36 B | -4.71% | 303 |
| 12/31/2024 | $73.51 B | -18.88% | 245 |
| 12/29/2023 | $90.62 B | 32.67% | 165 |
| 12/30/2022 | $68.3 B | -40.84% | 201 |
| 12/31/2021 | $115.46 B | 46.79% | 130 |
| 12/31/2020 | $78.66 B | 24.78% | 176 |
| 12/31/2019 | $63.04 B | 53.39% | 183 |
| 12/31/2018 | $41.1 B | 17.07% | 258 |
| 12/29/2017 | $35.1 B | 32.79% | 359 |
| 12/30/2016 | $26.43 B | 10.79% | 384 |
Company Profile
About Zoetis Inc.
Zoetis Inc. is a global leader in animal health, specializing in the discovery, development, manufacture, and commercialization of a wide range of veterinary products and services.
Product Offerings
- Medicines & Vaccines: Parasiticides, vaccines, dermatology treatments, anti-infectives, pain management, and sedation products.
- Diagnostics: Point-of-care diagnostic tools, rapid immunoassay tests, reference lab services, and blood glucose monitors.
- Non-Pharmaceutical Solutions: Nutritionals, biodevices, genetic tests, and precision animal health technologies.
Target Markets
Zoetis serves a diverse range of species, including:
- Livestock: Cattle, swine, poultry, fish, and sheep.
- Companion Animals: Dogs, cats, and horses.
Key Partnerships & Collaborations
The company collaborates with Blacksmith Medicines, Inc. to develop novel antibiotics for animal health.
Company Background
Founded in 1950, Zoetis is headquartered in Parsippany, New Jersey, and markets its products to veterinarians, livestock producers, and pet owners worldwide.
Frequently Asked Questions
-
What is Zoetis's (ZTS) current market cap?As of 06/26/2025, Zoetis (including the parent company, if applicable) has an estimated market capitalization of $69.36 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Zoetis (ZTS) rank globally by market cap?Zoetis global market capitalization ranking is approximately 303 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.